Aier(SZ:300015)2016-01-26 08:17Financial Performance - The company's net profit attributable to shareholders is expected to be approximately 417.40 million yuan, representing a year-on-year increase of 35%-45% compared to 309.19 million yuan in the previous year[3] - The total net profit for the reporting period is projected to be 448.32 million yuan[3] - The increase in performance is attributed to the growing demand in the ophthalmology market, expansion of operational scale, and improved brand influence[5] Non-Recurring Items - The company anticipates a negative impact of approximately 20 million yuan from non-recurring gains and losses on net profit[6] Audit and Reporting - The performance forecast has not been audited by a registered accountant[4] - The financial data presented is based on preliminary estimates by the company's finance department, with detailed figures to be disclosed in the annual report[7]